Neurology

The Pharmacy Times® Neurology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?

Caring for a Spouse With Dementia Increases Risk of Depressive Symptoms

The symptoms of depression in caregivers of patients with dementia exacerbates over time.

COVID-19 May Have Long Term Effects on the Brain

COVID-19 has been found in the brain post-mortem.

To Optimize the Patient Journey, Put the Patient First

Without coordinated care to ensure proper adherence, the resulting costs can become downright staggering for health systems.

Experts Say COVID-19 May Invade Central Nervous System, Causing Neurological Illnesses

Although cytokine storms are usually associated with severe COVID-19, study indicates less severe disease may also be at risk of cytokine storm.

Delirium Is Common for Patients With COVID-19 in ICU, With Potential Lasting Consequences

Delirium is a common syndrome experienced by patients with COVID-19 while being treated in the ICU, according to a session at the 2020 ASHP Midyear Clinical Meeting and Exhibition.

Pharmacy Focus Episode 14: The Neurological Impact of COVID-19

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Tau Protein Levels Can Help Predict Alzheimer Disease

The tau protein can help identify Alzheimer disease before cognitive decline begins.

Pharmacy Times: Week of December 7 Lineup

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week

Fun Fact: What Was a Common Treatment for Mental Illness in the 17th and 18th Centuries?

The treatment of mental illness has long been a quandary for medical professionals throughout history. But historically, mental illness has been more loosely defined than it is today.

Patients With Generalized Epilepsy Have Higher Risk for Obstructive Sleep Apnea

Compared with patients with focal epilepsy, those with genialized epilepsy have a higher risk of obstructive sleep apnea.

FDA Committee Does Not Recommend Approval of Aducanumab for Alzheimer Disease

A final vote that assessed whether the findings from the EMERGE trial served as primary evidence for the efficacy of aducanumab in Alzheimer disease was 10–0 that the trial did not provide evidence.

New Migraine Drugs Target Triptan Contraindication Population

The current acute treatments for migraines have shown efficacy and safety, however, approximately one-third of people do not respond, cannot use these options due to contraindications, or report dissatisfaction in therapy.

The Pharmacy Times® Neurology resource center provides a home for all of the latest clinical information that both neurologists and pharmacists that work within the field could find valuable. With articles covering updates from the robust pipeline of novel neurological therapies, and the newest data from all phases of clinical trials and studies in the space, it also serves as a hub of coverage from ongoing conferences and annual meetings of neurological associations.